KIMBERLY S UY

Eye and Vision Services Providers|Optometrist BROOKLYN, NY NPI 1013460120

General Payments — all program years on this page

$4,384.35

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $532.53 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $532.5321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $756.4611
2019 $617.4711
2020 $411.254
2021 $1,027.8010
2022 $589.666
2023 $449.1816
2024 $532.5321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106262758 ABBVIE INC. $13.80 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111730487 Amgen Inc. $21.31 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111730489 Amgen Inc. $16.54 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139138200 Tarsus Pharmaceuticals, Inc. $35.91 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139138202 Tarsus Pharmaceuticals, Inc. $40.41 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139138204 Tarsus Pharmaceuticals, Inc. $37.13 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140389048 Bausch & Lomb Americas Inc. $13.21 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140389050 Bausch & Lomb Americas Inc. $114.35 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140389052 Bausch & Lomb Americas Inc. $12.94 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140389054 Bausch & Lomb Americas Inc. $2.38 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140389056 Bausch & Lomb Americas Inc. $24.97 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140389058 Bausch & Lomb Americas Inc. $7.86 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147400648 Oyster Point Pharma, Inc. $21.70 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147403260 Oyster Point Pharma, Inc. $21.79 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147403800 Oyster Point Pharma, Inc. $23.78 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147405648 Oyster Point Pharma, Inc. $25.44 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147411283 Oyster Point Pharma, Inc. $21.79 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147411471 Oyster Point Pharma, Inc. $19.69 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147412468 Oyster Point Pharma, Inc. $19.89 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147422345 Oyster Point Pharma, Inc. $23.87 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152170498 SUN PHARMACEUTICAL INDUSTRIES INC. $13.77 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.